Mureddu Gian Francesco, D'Errigo Paola, Rosato Stefano, Faggiano Pompilio, Badoni Gabriella, Ceravolo Roberto, Altamura Vito, Di Martino Mirko, Ambrosetti Marco, Oliva Fabrizio, Ciccarelli Paola, Baglio Giovanni
Cardiac Rehabilitation Unit. San Giovanni-Addolorata Hospital, Roma, Italy.
ITACARE-P, (Italian Alliance for Cardiovascular Rehabilitation and Prevention), Roma, Italy.
Int J Cardiol Cardiovasc Risk Prev. 2024 Jul 6;22:200310. doi: 10.1016/j.ijcrp.2024.200310. eCollection 2024 Sep.
The reduction in long-term mortality after acute myocardial infarction (AMI) is less pronounced than that of in-hospital mortality among patients with AMI complicated by heart failure (HF) and/or in those with a high residual thrombotic risk (HTR).
To investigate the relative prognostic significance of HTR and HF in AMI survivors.
This retrospective cohort study enrolled patients admitted for AMI in 2014-2015 in all Italian hospitals. HTR was defined as at least one of the following conditions: previous AMI, ischemic stroke or other vascular disease, type 2 diabetes, renal failure. Patients were classified into four categories: uncomplicated AMI; AMI with HTR; AMI with HF and AMI with both HTR and HF (HTR + HF). Cox proportional hazard model was used to evaluate the impact of HTR, HF and HTR + HF on the 5-year prognosis. A time-varying coefficient analysis was performed to estimate the 5-year trend of HR for major averse cardiac and cerebrovascular events (MACCE).
a total of 174.869 AMI events were identified. The adjusted 5-year HR for MACCE was 1.74 (p < 0.0001) and 1.75 (p < 0.0001) in HTR and HF patients vs uncomplicated patients, respectively. The coexistence of HTR and HF furtherly increased the risk of MACCE (HR = 2.43, p < 0.0001) over the first 3 years after AMI.
Either HRT and HF confer an increased 5-year hazard of MACCE after AMI. The coexistence of HTR and HF doubled the overall 5-year risk of MACCE after AMI.
急性心肌梗死(AMI)合并心力衰竭(HF)和/或具有高残余血栓形成风险(HTR)的患者,其长期死亡率的降低不如住院死亡率明显。
探讨HTR和HF在AMI幸存者中的相对预后意义。
这项回顾性队列研究纳入了2014年至2015年期间在意大利所有医院因AMI入院的患者。HTR被定义为以下至少一种情况:既往AMI、缺血性中风或其他血管疾病、2型糖尿病、肾衰竭。患者被分为四类:无并发症的AMI;伴有HTR的AMI;伴有HF的AMI以及伴有HTR和HF的AMI(HTR + HF)。采用Cox比例风险模型评估HTR、HF和HTR + HF对5年预后的影响。进行时变系数分析以估计主要不良心脑血管事件(MACCE)的5年风险趋势。
共识别出174869例AMI事件。与无并发症的患者相比,HTR和HF患者MACCE的校正5年风险比分别为1.74(p < 0.0001)和1.75(p < 0.0001)。HTR和HF的共存进一步增加了AMI后前3年MACCE的风险(风险比 = 2.43,p < 0.0001)。
HTR和HF均使AMI后MACCE的5年风险增加。HTR和HF的共存使AMI后MACCE的总体5年风险增加一倍。